Immucor Lays SEC, Shareholder Actions To Rest

Law360, New York (September 28, 2007, 12:00 AM EDT) -- Immucor Inc. washed its hands this week of litigation that accused it of covering up its alleged involvement in a hospital bribery scandal in Italy, settling with the U.S. Securities and Exchange Commission and winning court approval of its $2.5 million deal with shareholders.

With its Thursday settlement with the SEC, which had accused it of Securities Exchange Act violations, the Norcross, Ga.-based blood transfusion instruments maker agreed to a cease-and-desist order but didn't have to pay any penalties. Chief executive Gioacchino De Chirico laid to...
To view the full article, register now.